Intrauterine adhesion
(IUA) is a common and prevailing complication
after uterine surgery, which can lead to clinical symptoms such as
a low menstrual volume, amenorrhea, periodic lower abdominal pain,
infertility, and so on. Placing a three-dimensional printing hydrogel
between the injured site and the adjacent tissue is considered to
be a physical barrier to prevent adhesion, which can isolate the damaged
area during the healing process. In this work, a tissue hydrogel with
various proportions of a methacrylated gelatin (GelMA) and methacrylated
collagen (ColMA) composite hydrogel loaded with amniotic mesenchymal
stem cells (AMSCs) was constructed by using three-dimensional biological
printing technology. Compared with the single GelMA hydrogel, the
composite antiadhesion hydrogel (GelMA/ColMA) showed an appropriate
swelling ratio, enhanced mechanical properties, and impressive stability.
Meanwhile, the microstructure of the GelMA/ColMA composite hydrogel
showed a denser and interconnected microporous structure. In addition,
the cytotoxicity study indicated that the GelMA/ColMA hydrogel has
a cytocompatibility nature toward AMSCs. Finally, the fabrication
of stem cell encapsulation hydrogels was studied, and the cells could
be released continuously for more than 7 days with the normal cell
function. The results of in vivo experiments indicated that the GelMA/ColMA/hAMSC
(human amnion mesenchymal stem cell) hydrogel can prevent cavity adhesion
in a rat IUA model. Therefore, bioprinting a biodegradable hydrogel
cross-linked by blue light has satisfactory anticavity adhesion effects
with excellent physical properties and biocompatibility, which could
be used as a preventive barrier for intrauterine adhesion.